Multiple relapses of visceral leishmaniasis in an adolescent with idiopathic CD4+ Lymphocytopenia associated with novel immunophenotypic and molecular features

Pediatric Infectious Disease Journal

Volumn 28, Issue 2, 2009, Pages 161-163

  Prigione, Ignazia ^a,b   Castagnola, Elio ^b   Imberti, Luisa ^c   Gambini, Claudio ^b   Gradoni, Luigi ^d   Dianzani, Umberto ^e   Ramenghi, Ugo ^f   Giacopelli, Francesca ^b   Moretta, Alessandro ^g   Moretta, Lorenzo ^g   Plebani, Alessandro ^h   Fischer, Alain ⁱ   Pistoia, Vito ^a  

^a Oncology Laboratory   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c SPEDALI CIVILI   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h UNIVERSITY OF BRESCIA   (Italy)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Immune deficiency; Relapsing visceral leishmaniasis

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CD4 ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; ANTIPRURITIC AGENT; KERATIN;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; FEMALE; FLOW CYTOMETRY; HUMAN; IDIOPATHIC CD4+ LYMPHOCYTOPENIA; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTOPENIA; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD; VISCERAL LEISHMANIASIS; IMMUNOLOGY; LYMPH NODE; METABOLISM; PATHOLOGY; RECURRENT DISEASE;

ADOLESCENT; ALLOPURINOL; AMPHOTERICIN B; ANTIPRURITICS; FEMALE; HUMANS; IMMUNOPHENOTYPING; KERATINS; LEISHMANIASIS, VISCERAL; LYMPH NODES; RECURRENCE; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE;

EID: 61949276262     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318185513d     Document Type: Article

References (14)

1. Fauci AS. CD4+ T-lymphocytopenia without HIV infection-no lights, no camera, just facts. N Engl J Med.1993;328:429-431.
2. Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4 + T-lymphocytopenia Task Force. NEngl JMed.1993;328:373-379.
3. McMahon-Pratt D, Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniasis or the visceral disease? Immunol Rev.2004;201:206-224.
4. di Martino L, Davidson RN, Giacchino R, et al. Treatment of visceral leishman- iasis inchildren with liposomal amphotericinB. JPediatr. 1997;131:271-277.
5. Cruz I, Nieto J, Moreno J, et al. Leishmania/HIV co-infections in the second decade. Indian JMed Res.2006;123:357-388.
6. Lopez-Medrano F, Aguado JM, Ruiz-Contreras J, et al. Idiopathic CD4+ T lymphocytopenia disclosed after the diagnosis of visceral leishmaniasis. Clin Infect Dis.2007;44:1522-1523.
7. Prigione I, Chiesa S, Taverna P, et al. T cell mediated immune responses to Toxoplasma gondiiin pregnant women with primary toxoplasmosis. Microbes Infect.2006;8:552-560.
8. Kong FK, Chen CL, Six A, et al. T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc Natl Acad Sci USA.1999;96:1536-1540.
9. He X, He X, Dave VP, et al. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature.2005;433: 826-833.
10. Macchi P, Villa A, Giliani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature.1995;377: 65-68.
11. Worth A, Thrasher AJ, Gaspar HB. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol. 2006;133:124-140
12. Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature.2006;444:110-114.
13. Castigli E, WilsonSA, GaribyanL, et al. TACI is mutant incommonvariable immunodeficiency and IgA deficiency. Nat Genet.2005;37:829-834.
14. Dereure J, Duong Thanh H, Lavabre-Bertrand T, et al. Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure. JInfect.2003;47: 77-81.